Effect of Targeting ApoC-III With Plozasiran on Lipoprotein Particle Size and Number in Hypertriglyceridemia
Christie M. Ballantyne, Daniel Gaudet, Robert S. Rosenson, Robert A. Hegele, Rong Zhou, Stacey Melquist, Jennifer Hellawell, Nicholas J. Leeper
Topics & Concepts
MedicineHypertriglyceridemiaInternal medicineParticle sizeCardiologyGastroenterologyTriglycerideCholesterolChemistryPhysical chemistryDiabetes, Cardiovascular Risks, and LipoproteinsCancer, Lipids, and MetabolismLipoproteins and Cardiovascular Health